Shi Dan, Li Huiyun, Zhang Junge, Li Yadong
Department of Oral Medicine Centre, Henan Provincial People's Hospital, Zhengzhou, Henan, People's Republic of China.
Department of Anesthesiology, Henan Provincial People's Hospital, Zhengzhou, Henan, People's Republic of China.
Cancer Manag Res. 2021 Feb 11;13:1371-1382. doi: 10.2147/CMAR.S277096. eCollection 2021.
Aberrant expression of circular RNA (circRNA) is involved in the occurrence and development of multifarious cancers, including oral squamous cell carcinoma (OSCC). However, the biological role of circGDI2 and the action mechanism in OSCC remain largely unclear.
The expression levels of circGDI2, miR-454-3p and forkhead box F2 (FOXF2) were examined by quantitative real-time PCR (qRT-PCR) or Western blot. The stability of circGDI2 was confirmed by Ribonuclease R (RNase R) assay. Cell Counting Kit 8 (CCK8) assay, colony formation and transwell assay were used to detect cell proliferation, migration or invasion. Cell apoptosis was tested by flow cytometry. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were employed to verify the interaction between miR-454-3p and circGDI2 or FOXF2. Moreover, xenograft mouse models were constructed to assess tumor growth in vivo.
CircGDI2 was a stable circRNA and was low expressed in OSCC tissues and cells. CircGDI2 overexpression could effectively inhibit the proliferation, migration, invasion and promote apoptosis in OSCC cells, and suppress OSCC tumor growth in nude mice in vivo. MiR-454-3p could be sponged by circGDI2, and its overexpression could mitigate the suppressive effects of circGDI2 overexpression on OSCC progression. In addition, FOXF2 was a target of miR-454-3p, and miR-454-3p silence could impede the cell growth of OSCC cells by enhancing FOXF2 expression. Meanwhile, circGDI2 positively regulated FOXF2 expression by targeting miR-454-3p.
CircGDI2 served as a repressor to restrain OSCC malignancy via miR-454-3p/FOXF2 axis, which might be a novel biomarker for targeted OSCC therapy.
环状RNA(circRNA)的异常表达参与了包括口腔鳞状细胞癌(OSCC)在内的多种癌症的发生和发展。然而,circGDI2在OSCC中的生物学作用及作用机制仍不清楚。
采用定量实时PCR(qRT-PCR)或蛋白质免疫印迹法检测circGDI2、miR-454-3p和叉头框F2(FOXF2)的表达水平。通过核糖核酸酶R(RNase R)分析确认circGDI2的稳定性。采用细胞计数试剂盒8(CCK8)分析、集落形成实验和Transwell实验检测细胞增殖、迁移或侵袭能力。通过流式细胞术检测细胞凋亡。采用双荧光素酶报告基因实验和RNA免疫沉淀(RIP)实验验证miR-454-3p与circGDI2或FOXF2之间的相互作用。此外,构建异种移植小鼠模型以评估体内肿瘤生长情况。
CircGDI2是一种稳定的circRNA,在OSCC组织和细胞中低表达。CircGDI2过表达可有效抑制OSCC细胞的增殖、迁移、侵袭并促进其凋亡,同时在体内抑制裸鼠OSCC肿瘤生长。MiR-454-3p可被circGDI2吸附,其过表达可减轻circGDI2过表达对OSCC进展的抑制作用。此外,FOXF2是miR-454-3p的靶标,miR-454-3p沉默可通过增强FOXF2表达来阻碍OSCC细胞的生长。同时,circGDI2通过靶向miR-454-3p正向调节FOXF2表达。
CircGDI2通过miR-454-3p/FOXF2轴作为抑制因子抑制OSCC的恶性进展,这可能是OSCC靶向治疗的一种新型生物标志物。